Paris, and Princeton, New Jersey (ots/PRNewswire) – -No added benefit on the composite primary end-point with the higher dose when entire ACS study population considered-
-Important new findings with higher loading dose of PLAVIX(R) for heart patients undergoing coronary angioplasty (PCI)-
Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical [...]
Tag Archive > Study Population
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Landmark EchoCRT trial enrolls first European patients
(pressebox) Berlin, 02.12.2008 – BIOTRONIK announces European rollout of the EchoCRT Trial investigating the life-saving benefits of cardiac resynchronization therapy in patients with heart failure who currently do not receive device therapy.
BIOTRONIK announced that the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of physicians [...]
